GeneralConnection.com
➔
Dictionary
Dictionary Search
Go Find!
xenon
Synonyms
Noun
1. Xe
2. atomic number 54, chemical element, element, noble gas, inert gas, argonon
Usage
Xenon Pharmaceuticals (XENE) Could Be 14% Undervalued If Its Epilepsy Narrative Holds - simplywall.st
Price to sales forward of Xenon Pharmaceuticals Inc. – TRADEGATE:XP0 - TradingView
Deciphering the “Missing Xenon Paradox” in Celestial Bodies: A Multifaceted Perspective Toward Demystifying This Enigma - AGU Publications
Analysts tout market potential of Xenon’s epilepsy drug on Phase III win - Clinical Trials Arena
Xenon gas does not help elite climbers - UW Homepage
Xenon Pharmaceuticals Inc. Rings the Opening Bell - Nasdaq
Xenon To Seek Approval of First-in-Class Epilepsy Drug After Exceeding Phase 3 Expectations - BioSpace
Krypton/Xenon separation at room temperature in a flexible coordinative framework sorbent - Nature
Xenon phase 3 epilepsy readout 'blows away' expectations, stock soars - Fierce Biotech
New model improves prediction of xenon behavior in molten salt reactors - anl.gov
JPMorgan Raises its Price Target on Xenon Pharmaceuticals (XENE) - Yahoo Finance
EyeCare4Kids Partners With Xenon Ophthalmics to Expand Access to Comprehensive Vision Exams - VisionMonday.com
Xenon Presents Azetukalner Phase 3 Seizure Study Results - The Clinical Trial Vanguard
Space race offers fresh growth path for krypton and xenon - gasworld
Xenon Pharmaceuticals Inc. Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why - Yahoo Finance
Xenon Pharmaceuticals (XENE) Is Down 6.7% After $650 Million Follow-On Offering And Phase 3 Epilepsy Win - Yahoo Finance
Xenon Pharmaceuticals Q1 Earnings Call Highlights - Yahoo Finance
Xenon to Report Q1 2026 Financial Results on May 7, 2026 - Yahoo Finance
Nova release ‘X-Alps winner’ Xenon 3 - Cross Country Magazine
Xenon Reports Q1 2026 Financial Results and Provides Business Update - Yahoo Finance
Xenon Pharmaceuticals stock hits all-time high at 63.96 USD - Investing.com
Xenon’s seizure drug study reads out soon. Here’s what to expect - STAT
Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS) - GlobeNewswire
Xenon Pharmaceuticals Announces Proposed Public Offering - Yahoo Finance
Xenon awards new hires 20,200 options and 11,850 RSUs - Stock Titan
Assessing Xenon Pharmaceuticals (XENE) Valuation After Recent Share Price Pullback And Modest Undervaluation Estimate - Yahoo Finance
Size-inverse molecular sieving xenon/krypton separation through cation-tuned gating effect within Linde Type A zeolites - Nature
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
RBC: Revolution, Xenon, Arrowhead among top takeover targets - BioPharma Dive
Price to book forward of Xenon Pharmaceuticals Inc. – NASDAQ:XENE - TradingView
Polarean Expands Xenon MRI Platform into Cardiopulmonary Drug Development - dicardiology.com
Xenon Pharmaceuticals’ seizure drug shows strong efficacy in late-stage trial - STAT
Rab Xenon Synthetic Jacket Review - Switchback Travel
Xenon Pharmaceuticals (XENE) Climbs 31.7% as Epilepsy Treatment Moves Forward - Yahoo Finance
Xenon Pharmaceuticals to Announce Topline Data from Phase 3 X-TOLE2 Study of Azetukalner for Focal Onset Seizures - Quiver Quantitative
A Look At Xenon Pharmaceuticals (XENE) Valuation After Phase 3 X TOLE2 Success And Extended Cash Runway - Yahoo Finance
What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing - The Motley Fool
Did Positive X-TOLE2 Data and a Major Cash Raise Just Shift Xenon Pharmaceuticals' (XENE) Investment Narrative? - Yahoo Finance
Xenon Pharmaceuticals surges 43.6% as Phase 3 azetukalner epilepsy data beats expectations | XENE Stock News - Quiver Quantitative
Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference - Yahoo Finance
Xenon to Present New Azetukalner Epilepsy Data at AES 2025 - The Clinical Trial Vanguard
Xenon Pharmaceuticals Stock Gains 22% in Six Months: Here's Why - Zacks Investment Research
Is Positive X-TOLE2 Epilepsy Data And 2026 FDA Filing Plan Altering The Investment Case For Xenon Pharmaceuticals (XENE)? - simplywall.st
Xenon Pharmaceuticals Inc. Prices Upsized Public Offering, Anticipated Gross Proceeds of Approximately $650 Million - Quiver Quantitative
Dark-Matter Sensitivity Improved with a Xenon Still - American Physical Society
Xenon Pharmaceuticals Inc (XENE) Looking At a $2 Billion Opportunity Here - Yahoo Finance
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update - Yahoo Finance
Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026 - GlobeNewswire
Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference - GlobeNewswire
Xenon Pharmaceuticals stock surges 40% on positive trial data - Investing.com
Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Xenon Pharmaceuticals Highlights Strong Phase III Azetukalner Data, Q3 NDA Plans at Bloom Burton Conference - Yahoo Finance
Xenon: Shares Soar On Seizure Data, But Valuation May Be Overcooked (NASDAQ:XENE) - Seeking Alpha
Xenon Pharmaceuticals faces earnings test as launch nears By Investing.com - Investing.com Nigeria
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
655 S Xenon Ct, Lakewood, CO 80228 - Realtor.com
Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know - The Motley Fool
Neuronal ‘off switch’ gets closer to reality - Nature
Can Xenon Help You Climb Everest Faster? These Scientists Aren't Buying the Hype. - Outside Magazine
Worth the wait: Xenon’s azetukalner exceeds expectations in FOS - BioWorld News
Xenon Pharmaceuticals: Derisked Pipeline Ahead Of Critical 2026 Phase 3 Readout (NASDAQ:XENE) - Seeking Alpha
Xenon Pharmaceuticals prices $650M public offering at $57/share - Investing.com
XENON Launches CIXL Pulsed Light System for Food Safety, Pathogen Control - Food Safety Magazine
Xenon Pharmaceuticals Stock Scores RS Rating Upgrade - Investor's Business Daily
Is It Too Late To Consider Xenon Pharmaceuticals (XENE) After A 58% One-Year Surge? - simplywall.st
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Xenon brings 48-month epilepsy drug data and Phase 3 results to AAN - Stock Titan
List of 23 Acquisitions by Xenon Private Equity (Apr 2026) - Tracxn
BofA raises Xenon Pharmaceuticals price target on trial success - Investing.com
Biotech Xenon raises $650M in stock sale at $57 a share - Stock Titan
Xenon Pharmaceuticals to report epilepsy drug trial results Monday - Investing.com
Polarean Highlights New CHEST Journal Study Demonstrating Xenon MRI Predicts Cystic Fibrosis Exacerbations - BioSpace
Xenon Pharmaceuticals Nets $707.7 Million in $57 Share Offering With Pre-Funded Warrants - TradingView
Nearly 40% stayed seizure-free for a year in Xenon’s 48-month study - Stock Titan
Can Xenon Gas Really Replace Traditional Acclimatization on Mount Everest? - Global Rescue LLC
Xenon lines up four investor conference presentations in Q2 2026 - Stock Titan
Xenon's Phase 3 Supports A 'Buy' Despite Its Premium (NASDAQ:XENE) - Seeking Alpha
What Do Recent Insider Sales at Xenon Pharmaceuticals Signal - Kavout | AI
Xenon Pharmaceuticals Clears Key Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily
May 7 after the bell: Xenon to give Q1 update, host webcast - Stock Titan
Xenon Pharmaceuticals Awaits Key Study Results Amid Analyst Upgrades - StocksToTrade
Xenon Pharmaceuticals Stock Gains 22% in Six Months: Here's Why - The Globe and Mail
Xenon Pharmaceuticals stock surges 40% on positive trial data By Investing.com - Investing.com Nigeria
Xenon Pharmaceuticals’ Strategic Moves Signal New Opportunities in Epilepsy Screening - timothysykes.com
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Xenon targets US FDA filing for azetukalner after positive Phase III epilepsy data - AllSci
Xenon (XENE) director receives RSUs, options and adds common shares - Stock Titan
Xenon Q1 Earnings Match Estimates, Pipeline Development in Focus - TradingView
Xenon Pharmaceuticals (XENE) director receives new RSUs, options and RSU vesting - Stock Titan
Xenon Pharmaceuticals Inc. (XENE) Discusses Positive Top Line Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures - Slideshow (NASDAQ:XENE) 2026-03-09 - Seeking Alpha
Xenon surges as epilepsy drug delivers strong late‑stage results - whbl.com
Is Xenon merely a neuroprotectant? An overlooked immunomodulatory potential | Journal of Translational Medicine - Springer Nature Link
[144] Xenon Pharmaceuticals Inc. SEC Filing - Stock Titan
Xenon gets Phase 3 win with epilepsy drug, fueling blockbuster hopes for its first launch - Endpoints News
Xenon Pharmaceuticals Inc. (XENE) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
Xenon Gas Shows Promise in Treating Alzheimer’s Disease; Human Trials to Follow - Anesthesiology News
Assessing Xenon Pharmaceuticals (XENE) Valuation After A Recent Pullback And Strong Multi Year Returns - simplywall.st
EyeCare4Kids and Xenon Ophthalmics Donate 1,000 Vision Exam Systems to Expand Access to Eye Care - InvisionMag.com
Foreign Language Equivalents
Foreign Language Equivalents of 'xenon'
Language
Equivalent
Language
Equivalent
French
Spanish
Misspellings - Typos
xenonn, xxenon, enon, xemon, xenn, xenpn, xwnon, xnon, xennon, cenon, xeonn, xenob, xenoon, exnon, zenon, xeno, xenom, xenin, xrnon, xneon, xenno, xebon, xeenon, xeon
Words Starting with Letter - 'C'
c
c and w
c battery
c clef
c compiler
c horizon
c program
c-clamp
c-horizon
c-note
c-ration
c-reactive protein
c-section
c. d. gibson
c. diphtheriae
c. h. best
c. k. ogden
c. northcote parkinson
c. p. snow
c. psittaci
c. s. forester
c. s. lewis
c. trachomatis
c. vann woodward
Go to Page 1
Go to Page 2 »
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z